Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular

Arun Krishnamoorthy1, Timothy Brown, Colby R Ayers

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA.

Insights

Concentric left ventricular hypertrophy (LVH) infrequently leads to reduced ejection fraction (EF) long-term, especially without myocardial infarction. When reduced EF occurs, LV geometry typically remains concentric.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Clinical Medicine

Background:

  • Concentric left ventricular hypertrophy (LVH) is a common finding, but its progression to depressed left ventricular ejection fraction (LVEF) is not well understood.
  • Previous studies have not definitively established whether LVH is a direct precursor to reduced LVEF in humans.

Purpose of the Study:

  • To investigate the incidence and characteristics of LVEF decline in patients with pre-existing concentric LVH.
  • To determine the influence of myocardial infarction (MI) and follow-up duration on the development of depressed LVEF.

Main Methods:

  • Retrospective analysis of 555 patients with LVH and normal LVEF identified via echocardiography (1992-1994).
  • Follow-up LVEF assessment was available for 220 patients, categorized into short (≤7.5 years) and long (>7.5 years) term follow-up.
  • Primary outcome: development of qualitatively depressed LVEF. Subgroup analysis included presence or absence of interval MI.

Main Results:

  • After a median follow-up of 7.5 years, 20% of patients with concentric LVH developed a depressed LVEF.
  • The incidence of low LVEF was significantly higher in patients with interval MI (50% short-term, 44% long-term) compared to those without (13% short-term, 20% long-term).
  • Patients who developed reduced LVEF maintained a concentric LV geometry.

Conclusions:

  • The transition from concentric LVH to depressed LVEF is relatively infrequent (20%) over long-term follow-up, particularly in the absence of myocardial infarction.
  • Myocardial infarction is a significant risk factor for developing reduced LVEF in patients with concentric LVH.
  • LV geometry typically remains concentric even after the development of depressed LVEF in this cohort.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...